Free Trial

AFP reporting that the EU has authorised the.....>

EU
EU: AFP reporting that the EU has authorised the use of the drug remdesivir to
treat COVID-19. The drug has been shown to reduce the time-span of symptoms
COVID-19 suffered experience. 
- Comes days after almost all of the world's supply of the drug for the next
three months was purchased by the United States. 

To read the full story

Close

Why MNI

MNI is the leading provider

of intelligence and analysis on the Global Fixed Income, Foreign Exchange and Energy markets. We use an innovative combination of real-time analysis, deep fundamental research and journalism to provide unique and actionable insights for traders and investors. Our "All signal, no noise" approach drives an intelligence service that is succinct and timely, which is highly regarded by our time constrained client base.

Our Head Office is in London with offices in Chicago, Washington and Beijing, as well as an on the ground presence in other major financial centres across the world.